Gemtuzumab ozogamicin Antibody
Gemtuzumab ozogamicin is a CD33-targeting antibody-drug conjugate (ADC) that delivers the potent cytotoxin calicheamicin. It is a key research tool for studying acute myeloid leukemia (AML), with applications in both in vitro cell assays and in vivo xenograft models to investigate ADC mechanisms and therapeutic efficacy.
Product Specifications
Target
Apoptosis, Antibody-Drug Conjugates (ADCs)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
